These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37889274)

  • 41. Scirrhous hepatocellular carcinoma: comparison with usual hepatocellular carcinoma based on CT-pathologic features and long-term results after curative resection.
    Kim SH; Lim HK; Lee WJ; Choi D; Park CK
    Eur J Radiol; 2009 Jan; 69(1):123-30. PubMed ID: 17976942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
    Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
    Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma.
    Liau KH; Ruo L; Shia J; Padela A; Gonen M; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; DeMatteo RP
    Cancer; 2005 Nov; 104(9):1948-55. PubMed ID: 16196045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series.
    Sapisochin G; Bilbao I; Balsells J; Dopazo C; Caralt M; Lázaro JL; Castells L; Allende H; Charco R
    World J Surg; 2010 Sep; 34(9):2146-54. PubMed ID: 20411387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A model incorporating histopathology and preoperative gadoxetic acid-enhanced MRI to predict early recurrence of hepatocellular carcinoma without microvascular invasion after curative hepatectomy.
    Qu Q; Lu M; Xu L; Zhang J; Liu M; Jiang J; Zhao X; Zhang X; Zhang T
    Br J Radiol; 2023 Mar; 96(1144):20220739. PubMed ID: 36877238
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of ultrasound-, computed tomography-, and magnetic resonance imaging-guided radiofrequency ablation for hepatocellular carcinoma.
    Yuan C; Yuan Z; Cui X; Gao W; Zhao P; He N; Cui S; Wang Y; Zhang Y; Li W; Zheng J
    J Cancer Res Ther; 2019; 15(4):784-792. PubMed ID: 31436232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.
    Kang TW; Rhim H; Lee J; Song KD; Lee MW; Kim YS; Lim HK; Jang KM; Kim SH; Gwak GY; Jung SH
    Eur Radiol; 2016 Oct; 26(10):3437-46. PubMed ID: 26747262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of early treatment response to radiotherapy for HCC using pre- and post-treatment MRI.
    Song SH; Jeong WK; Choi D; Kim YK; Park HC; Yu JI
    Acta Radiol; 2019 Jul; 60(7):826-835. PubMed ID: 30282483
    [No Abstract]   [Full Text] [Related]  

  • 49. Prognosis of hepatocellular carcinoma with biliary tumor thrombi after liver surgery.
    Noda T; Nagano H; Tomimaru Y; Murakami M; Wada H; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Kim T; Wakasa K; Doki Y; Mori M
    Surgery; 2011 Mar; 149(3):371-7. PubMed ID: 20869094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.
    Yang SL; Liu LP; Sun YF; Yang XR; Fan J; Ren JW; Chen GG; Lai PB
    J Gastroenterol; 2016 Jul; 51(7):722-32. PubMed ID: 26607653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Techniques of parenchyma-sparing hepatectomy for the treatment of tumors involving the hepatocaval confluence: A reliable way to assure an adequate future liver remnant volume.
    Urbani L; Colombatto P; Balestri R; Licitra G; Leoni C; Forfori F; Masi G; Boraschi P; Castagna M; Buccianti P
    Surgery; 2017 Sep; 162(3):483-499. PubMed ID: 28549521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.
    Zhang XY; Luo Y; Wen TF; Jiang L; Li C; Zhong XF; Zhang JY; Ling WW; Yan LN; Zeng Y; Wu H
    World J Gastroenterol; 2014 Sep; 20(35):12628-36. PubMed ID: 25253968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MRI features of hepatocellular carcinoma related to biologic behavior.
    Cho ES; Choi JY
    Korean J Radiol; 2015; 16(3):449-64. PubMed ID: 25995679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical operation and re-operation for hepatocellular carcinoma with bile duct thrombosis.
    Wang YD; Xue HZ; Jiang QF; Shen Q; Wang LC; Zhang X; Lu B; Yu M; Li K
    Chin Med J (Engl); 2010 Aug; 123(16):2163-70. PubMed ID: 20819658
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Computed tomography-based radiomics to predict early recurrence of hepatocellular carcinoma post-hepatectomy in patients background on cirrhosis.
    Qian GX; Xu ZL; Li YH; Lu JL; Bu XY; Wei MT; Jia WD
    World J Gastroenterol; 2024 Apr; 30(15):2128-2142. PubMed ID: 38681988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocellular carcinoma with a prominent vascular scar in the center: MR imaging findings.
    Yamauchi M; Asayama Y; Yoshimitsu K; Irie H; Tajima T; Hirakawa M; Ishigami K; Nakayama T; Kakihara D; Yamaguchi K; Nishihara Y; Aishima S; Honda H
    Radiat Med; 2006 Jul; 24(6):467-70. PubMed ID: 16958431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
    Lee S; Kim KW; Jeong WK; Kim MJ; Choi GH; Choi JS; Song GW; Lee SG
    Eur Radiol; 2020 Feb; 30(2):987-995. PubMed ID: 31471754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment.
    Cho HJ; Kim B; Kim HJ; Huh J; Kim JK; Lee JH; Seo CW; Ahn HR; Eun JW; Kim SS; Cho SW; Cheong JY
    Eur Radiol; 2020 Aug; 30(8):4182-4192. PubMed ID: 32189053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subcentimeter hepatocellular carcinoma (HCC) on gadoxetic-acid-enhanced MRI: less frequent typical imaging features compared to 1-2 cm HCC but better prognosis after surgical resection.
    Huang P; Shi Q; Ni X; Liu L; Zhou C; Wu F; Wang C; Xiao Y; Miao G; Yang C; Zeng M
    Abdom Radiol (NY); 2023 Nov; 48(11):3391-3400. PubMed ID: 37656218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.